These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 13563145)
21. [Antibiotic therapy of staphylococcus septicemia]. BASTRUP-MADSEN P; NØRBY G Nord Med; 1952 Feb; 47(7):201-3. PubMed ID: 14910973 [No Abstract] [Full Text] [Related]
22. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics. WISE RI; VOIGT AE; COLLIN MV; CRANNY CL AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420 [No Abstract] [Full Text] [Related]
23. Novobiocin; a limited bacteriologic and clinical study of its use in forty-five patients. NICHOLS RL; FINLAND M Antibiotic Med Clin Ther (New York); 1956 Apr; 2(4):241-57. PubMed ID: 13303120 [No Abstract] [Full Text] [Related]
24. Correlation between in vitro studies and response to antibiotic therapy in staphylococcic bacteremia. ABBOUD FM; WAISBREN BA AMA Arch Intern Med; 1959 Aug; 104(2):226-33. PubMed ID: 13669776 [No Abstract] [Full Text] [Related]
25. The management of hospital-acquired staphylococcal infections. YOW EM; YOW MD; WOMACK GK; SAKUMA T; MONZON OT AMA Arch Intern Med; 1958 Dec; 102(6):948-59. PubMed ID: 13593902 [No Abstract] [Full Text] [Related]
26. Comparative sensitivity to antibiotics of skin staphylococci. HSIANG CM Chin Med J; 1958 Jul; 77(1):79-83. PubMed ID: 13573538 [No Abstract] [Full Text] [Related]
27. The effect of antibiotic therapy on the emergence of resistant staphylococci in cutaneous bacterial infections. LIVINGOOD CS; GREER JE; BURNS RE; MENARD RR J Invest Dermatol; 1959 Apr; 32(4):485-93. PubMed ID: 13654833 [No Abstract] [Full Text] [Related]
28. Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains. BARBER M; CSILLAG A; MEDWAY AJ Br Med J; 1958 Dec; 2(5109):1377-80. PubMed ID: 13596614 [No Abstract] [Full Text] [Related]
29. Magnamycin, a new antibiotic. FINN JJ; KANE LW Bull New Engl Med Cent; 1952; 14(4):113-6. PubMed ID: 13009389 [No Abstract] [Full Text] [Related]
30. [Enterotoxicosis due to Micrococcus pyogenes aureus after sanclomycin treatment; cure by erythromycin]. BERNAY P Arch Mal Appar Dig Mal Nutr; 1956 Oct; 45(10):276-7; discussion, 277-8. PubMed ID: 13373476 [No Abstract] [Full Text] [Related]
31. THE OBSTINATE Staphylococcus. Med World; 1956 Aug; 85(2):128-9. PubMed ID: 13358373 [No Abstract] [Full Text] [Related]
32. Staphylococcic endocarditis; an analysis of 25 cases treated with antibiotics, together with a review of the recent literature. DOWLING HF; LEPPER M; CALDWELL ER; SPIES HW Medicine (Baltimore); 1952 May; 31(2):155-76. PubMed ID: 14940409 [No Abstract] [Full Text] [Related]
33. Use of ristocetin (spontin) in staphylococcal infections. BUSH LF Antibiot Annu; 1958-1959; 6():454-7. PubMed ID: 13637783 [No Abstract] [Full Text] [Related]
34. Ristocetin in adults and children. TERRY RB; BRADLEY LF Antibiot Annu; 1958-1959; 6():458-63. PubMed ID: 13637784 [No Abstract] [Full Text] [Related]
35. Ristocetin: a clinical trial. VAN ROOYEN CE; MACLEOD AJ; EMBREE G Can Med Assoc J; 1958 Nov; 79(9):723-5. PubMed ID: 13585306 [No Abstract] [Full Text] [Related]
36. Failure of ristocetin therapy in three cases of staphylococcal sepsis with bacteremia. RANTZ LA; JAWETZ E N Engl J Med; 1958 Nov; 259(20):963-6. PubMed ID: 13600603 [No Abstract] [Full Text] [Related]
37. Hospital cross-infections with staphylococci resistant to several antibiotics. CLARKE SK; DALGLEISH PG; GILLESPIE WA Lancet; 1952 Jun; 1(6719):1132-5. PubMed ID: 14928602 [No Abstract] [Full Text] [Related]